Table 2 Clinical data of the final cohort
Final cohort (n = 166 hips) | ||||
|---|---|---|---|---|
Mean | ±SD | Median | Range | |
Follow-up (yrs) | 8.4 | ± 0.8 | 8 | (7 to 11) |
Pre-op HHS Total | 41.7 | ± 13.1 | 42 | (10 to 74) |
Pain | 10.3 | ± 7.7 | 10 | (0 to 30) |
Function | 25.1 | ± 7.6 | 26 | (0 to 42) |
Mobility | 2.0 | ± 0.3 | 2 | (1 to 3) |
Attitude | 3.9 | ± 0.3 | 4 | (2 to 4) |
Post-op HHS Total | 83.6 | ± 13.2 | 86 | (8 to 99) |
Pain | 41.0 | ± 6.7 | 44 | (2 to 44) |
Function | 35.2 | ± 9.9 | 37 | (0 to 47) |
Mobility | 3.2 | ± 0.6 | 3 | (0 to 5) |
Attitude | 4.0 | ± 0.2 | 4 | (3 to 4) |
HHS Total Improvement | 41.5 | ± 17.7 | 42 | (−35 to 76) |
Pain | 30.9 | ± 10.5 | 34 | (−10 to 44) |
Function | 10.9 | ± 11.6 | 11 | (−31 to 42) |
Mobility | 1.1 | ± 0.7 | 1 | (−2 to 3) |
Attitude | 0.0 | ± 0.3 | 0 | (−1 to 2) |
Post-op OHS | 20.3 | ± 6.7 | 19 | (12 to 42) |
Post-op Pain on VAS | 0.6 | ± 1.3 | 0 | (0 to 7) |
Devane activity grade | ||||
1 | 20 | (12%) | ||
2 | 56 | (34%) | ||
3 | 61 | (37%) | ||
4 | 21 | (13%) | ||
5 | 4 | (2%) | ||
na | 4 | (2%) | ||